Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.
about
Barrett's oesophagus and adenocarcinomaMolecular biology of Barrett's adenocarcinoma.Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridizationLow Level of Her-2 Locus Amplification by Fluorescent In Situ Hybridization Does Not Correlate with Her-2 Protein Overexpression by Immunohistochemistry in Barrett's Esophagus.Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic ImplicationsThe HER-2/neu oncogene in tumors of the gastrointestinal tract.Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus.Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.Relative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer.Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma.c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.Esophageal cancer: current and emerging therapy modalities.Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.Her-2/neu testing and therapy in gastroesophageal adenocarcinoma.Systematic review and meta-analysis of the influence of HER2 expression and amplification in operable oesophageal cancer.Advances in biomarkers for esophageal cancer.Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis.Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha.HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH)The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study.C-erbB-2 Immunostaining in Laryngeal Cancer
P2860
Q24791935-D3A0F193-BF83-4C84-82D4-C652448482EEQ30327935-8D2BFE58-B125-435D-A570-657017365D11Q30992830-74EC8C7F-0C24-401A-B396-B03C944B8DA6Q33863322-B32E8278-301B-40E5-8CCF-657E22C8D865Q33984756-8DAC716B-B1B9-49F7-BD3D-47E582C5A0F0Q34223494-104BED97-21C0-4C79-BE82-37F8795A9F52Q34311106-B93AEF34-4A1A-41B3-89D7-BE3E136A5BB1Q34319309-4DB0A336-5E9F-4481-BE76-74D05989AEECQ35770045-1124C388-E64A-498D-81DB-8D4B6FD0CA8AQ36140927-20B59F85-5EC8-4C3B-8C25-D6A1A267560DQ36410392-90D7C1EC-F8D5-4058-85D1-656EBD67F371Q36666667-5031A4DC-A9A3-4D33-B8DF-6E236855B934Q37256684-5BE1CE25-C6D5-4E48-918A-820B1CF4A2CFQ37256825-B7BD7690-2500-4669-A717-7A34BFA9E854Q37398079-654EC103-6416-4964-9F46-DF7ED0CA1728Q37522215-1A9AA547-D2FB-4983-A690-DA513AF1128FQ37824265-C58BBC3B-C058-46EA-B7D6-3C168A18689BQ38030442-8210FCAF-BF36-4235-8D3D-3648A639C854Q38153443-4BCFB6B2-F60E-4739-8BCA-3897BFE1AE43Q38412375-D4067417-9A0F-4D08-99CA-10F53290747CQ39833303-75896446-A09E-4F4A-B2C2-6C622EF847EEQ40220702-4B092498-E089-4993-8435-5FF93F418487Q41880900-1D9F89EE-3272-4944-A348-6AB977D09A7CQ43500705-34A309F1-BD5E-4B32-97B9-C114366DBB92Q58270535-5BF40CDC-3494-4F58-AE95-8229D8380B04
P2860
Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1994
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of c-erbB-2 oncogen ...... l and prognostic correlations.
@en
Expression of c-erbB-2 oncogen ...... l and prognostic correlations.
@nl
type
label
Expression of c-erbB-2 oncogen ...... l and prognostic correlations.
@en
Expression of c-erbB-2 oncogen ...... l and prognostic correlations.
@nl
prefLabel
Expression of c-erbB-2 oncogen ...... l and prognostic correlations.
@en
Expression of c-erbB-2 oncogen ...... l and prognostic correlations.
@nl
P2093
P2860
P356
P1476
Expression of c-erbB-2 oncogen ...... l and prognostic correlations.
@en
P2093
P2860
P356
10.1136/JCP.47.1.23
P407
P577
1994-01-01T00:00:00Z